ArticleOncogene2016

EGFR-targeted mAb therapy modulates autophagy in head and neck squamous cell carcinoma through NLRX1-TUFM protein complex.

Y Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.